KAO JOHN E 4

What Happened John E. Kao, CEO of Alignment Healthcare, sold 118,000 shares on 2026-03-23 in an open-market/private sale for a total of $2,062,439. The filing reports a weighted-average sale price of $17.48 per share; individual trades ranged from $17.07 to $17.81.

Key Details

• Transaction date: 2026-03-23; weighted-average price $17.48; price range $17.07–$17.81 (multiple trades).
• Total proceeds: $2,062,439.
• Shares owned after transaction: not specified in the provided filing summary; the filing indicates the shares were held by the JEK Trust (see footnote).
• Footnotes: F1 — sale executed under a Rule 10b5-1 plan adopted 11/21/2025; F2 — weighted-average price with per-trade range, detailed breakdown available on request; F3 — shares held by JEK Trust (dated Feb 8, 2021), of which Mr. Kao is trustee.
• Filing timeliness: Form 4 filed for the report dated 2026-03-23 (no late filing flagged).

Context

• This is a sale (often routine) and was carried out under a pre-established 10b5-1 trading plan, which typically allows insiders to sell shares on a preset schedule regardless of subsequent company news.
• The filing does not indicate option exercises, gifts, or tax-withholding; it reports a straight sale of shares.